15.1 C
New York
Friday, September 29, 2023

This Is Too Hot For Nektar Therapeutics (NASDAQ: NKTR), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Nektar Therapeutics (NKTR) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0181, or -2.64%, to $0.6669. The Nektar Therapeutics has recorded 94,645 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Nektar Therapeutics Announces Promising New Data from Phase 1b Study of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

As a NASDAQ listed company, NKTR falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.69 and fluctuated between $0.7156 as its day high and $0.6501 as its day low. The current market capitalization of Nektar Therapeutics is $122.93M. A total of 1.44 million shares were traded on the day, compared to an average of 7.01M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, NKTR has seen 0 BUY and 3 SELL insider trades, representing the acquisition of 0 and the disposition of 36,922 shares. Over the last 12 months, there were 0 BUYs and 18 SELLs from insiders. Insiders purchased 0 shares during that period but sold 238,033.

In the most recent transaction, ROBIN HOWARD W sold 19,998 shares of NKTR for 0.78 per share on Aug 16. After the transaction, the President & CEO now owns 919,799 company shares. In a previous transaction on Aug 16, Zalevsky Jonathan sold 9,703 shares at 0.78 per share. NKTR shares that Chief R&D Officer owns now total 283,685.

Among the insiders who sold shares, Wilson Mark Andrew disposed of 7,221 shares on Aug 16 at a per-share price of $0.78. This resulted in the Chief Legal Officer holding 250,959 shares of NKTR after the transaction. In another insider transaction, WHITFIELD ROY A sold 30,000 shares at $0.57 per share on Jun 14. Company shares held by the Director now total 216,250.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for NKTR in the last 3 months, the mean price target is $2.65 with high estimates of $6.00 and low estimates of $0.60. In terms of 52-week highs and lows, NKTR has a high of $4.36 and a low of $0.51.

As of this writing, NKTR has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.27. The company reported an EPS of -$0.73 in the last quarter, which was -192.00% lower than expectations of -$0.25.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NKTR’s latest balance sheet shows that the firm has $733.96M in Cash & Short Term Investments as of fiscal 2021. There were $143.18M in debt and $85.20M in liabilities at the time. Its Book Value Per Share was $1.04, while its Total Shareholder’s Equity was $679.51M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTR is Buy with a score of 2.63.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles